Craft

GSK

Stock Price

£14.5

2024-10-29

Market Capitalization

£653.7 M

2024-08-23

Revenue

£30.3 B

FY, 2023

GSK Summary

Company Summary

Overview
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company develops vaccines against infectious diseases and provides a portfolio of medicines in respiratory, HIV, immuno-inflammation, and oncology. GSK combines science and consumer insights aiming to create everyday healthcare brands for oral health, pain relief, cold, flu and allergy relief, digestive health, and vitamins, minerals, and supplements.
Type
Public
Status
Active
Founded
2000
HQ
Brentford, GB | view all locations
Website
https://www.gsk.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Emma Walmsley

    Emma Walmsley, Chief Executive Officer, Director

  • Iain MacKay

    Iain MacKay, Chief Financial Officer, Director

  • Hal Barron

    Hal Barron, Chief Scientific Officer and President, R&D, Director

  • Diana Conrad

    Diana Conrad, Chief People Officer

Operating MetricsView all

Phase II Trials Products

6
14.3%

FY, 2021

Healthcare Products in Development

64
8.5%

FY, 2021

Phase I Trials Products

16
33.3%

FY, 2021

LocationsView all

149 locations detected

  • Brentford HQ

    United Kingdom

    980 Great West Rd

  • Durham, NC

    United States

    410 Blackwell St

  • Philadelphia, PA

    United States

    2929 Walnut St Ste 1700

  • Boumerdes, Boumerdès Province

    Algeria

    Zone Industrielle Boudouaou

  • San Fernando, Provincia de Buenos Aires

    Argentina

    Carlos Casares 3690

  • Abbotsford, VIC

    Australia

    Level 3, 436 Johnston Street

and 143 others

GSK Financials

Summary Financials

Revenue (Q3, 2024)
£8.0B
Gross profit (Q3, 2024)
£6.7B
Net income (Q3, 2024)
£65.0M
Cash (Q3, 2024)
£3.2B
EBIT (Q3, 2024)
£188.0M
Enterprise value
$13.5B

Footer menu